Stocktoria

Jyong Biotech Ltd. MENS

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2025-06-17

Jyong Biotech Ltd. statistics & valuation

Market cap$142.9M
Net debt$2.1M
Enterprise value USD$145.1M
Earnings yield EBIT/EV-1.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
20242025
Shares outstanding
73.4M 76.0M 20242025
Net debt ($)
$2.1M 20242025
Share buybacks ($)
20242025
Return on assets (%)
-47.40% -22.50% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$0.04 -$0.06 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-22.5%-47.4%
Return on equity18.8%8.3%
Debt / equity-0.09×—
Current ratio0.450.02

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.